A batch of common drugs such as Banlangen Granules and Norfloxacin Capsules were found to be unqualified

On November 28, Guangdong Drug Administration issued the notice on the information of drug random inspection (No 8, 2019), which announced that 19 batches of drugs were unqualified in the random inspection, involving 14 drug manufacturers According to the notice, in order to strengthen the supervision of drug quality and ensure the safety of drug use by the public, according to the drug sampling plan of Guangdong Province in 2019, Guangdong Drug Administration organized the random inspection and inspection of drug quality of drug production, trading enterprises and medical institutions across the province After verification and confirmation, 19 batches of 19 varieties and 19 batches of drugs in this period failed to meet the standards, including 12 batches in circulation and 7 batches in use The main non-conforming items include properties, loading differences, disintegration time limit, water content, dissolution, related substances, particle size, content determination, etc At present, Guangdong Provincial Drug Administration has ordered the relevant municipal market supervision bureau to take necessary control measures such as sealing up, detaining, suspending sales, recalling, etc for the unqualified drugs in the inspection, to investigate and punish the production enterprises and the sampled units according to the relevant laws and regulations, and to continue the follow-up random inspection for these drugs List of drugs that do not meet the requirements through spot check in circulation